Clinical advances and practice updates in genitourinary cancers: a 2024 review from the multidisciplinary Spanish 'Cambados annual meeting'.

IF 2.5 3区医学 Q2 ONCOLOGY Clinical & Translational Oncology Pub Date : 2025-08-01 Epub Date: 2025-02-17 DOI:10.1007/s12094-025-03850-z

Ignacio Peláez, Martín Lázaro-Quintela, Daniel Pérez-Fentes, Emilio Esteban-González, Enrique Gallardo, Carlos Álvarez-Fernández, Pablo Álvarez Rodríguez, Urbano Anido-Herranz, Cristina Azpitarte Raposeiras, Ángel Maximino Castro-Iglesias, Ovidio Fernández Calvo, Natalia Fernández Núñez, Alicia Folgar-Torres, Carme García Lorenzo, Aránzazu González-Del-Alba, María José Méndez-Vidal, Aurea Molina Díaz, Ignacio Rodríguez Gómez, Sergio Vázquez-Estévez

{"title":"Clinical advances and practice updates in genitourinary cancers: a 2024 review from the multidisciplinary Spanish 'Cambados annual meeting'.","authors":"Ignacio Peláez, Martín Lázaro-Quintela, Daniel Pérez-Fentes, Emilio Esteban-González, Enrique Gallardo, Carlos Álvarez-Fernández, Pablo Álvarez Rodríguez, Urbano Anido-Herranz, Cristina Azpitarte Raposeiras, Ángel Maximino Castro-Iglesias, Ovidio Fernández Calvo, Natalia Fernández Núñez, Alicia Folgar-Torres, Carme García Lorenzo, Aránzazu González-Del-Alba, María José Méndez-Vidal, Aurea Molina Díaz, Ignacio Rodríguez Gómez, Sergio Vázquez-Estévez","doi":"10.1007/s12094-025-03850-z","DOIUrl":null,"url":null,"abstract":"<p><p>Prostate, bladder and kidney neoplasms are among the most prevalent genitourinary (GU) cancers worldwide. Significant therapeutic advancements in recent years have substantially improved patient outcomes. In response to this rapid progress, the Santiago de Compostela Health Research Institute (IDIS) has organized the annual 'Cambados Consensus Forum on Genitourinary Tumors' (Pontevedra, Spain) since 2018. This 2-day multidisciplinary meeting gathers Spanish medical oncologists, radiation oncologists, urologists, and hospital pharmacists to present and discuss the latest evidence in the field, merging from international congresses or journal publications. This review provides an overview of the most recent evidence regarding therapeutic advances in prostate cancer, renal cell carcinoma, and bladder cancer presented at the 2024 meeting (October), with a special focus on practice-changing innovations.</p>","PeriodicalId":50685,"journal":{"name":"Clinical & Translational Oncology","volume":" ","pages":"3307-3324"},"PeriodicalIF":2.5000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical & Translational Oncology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12094-025-03850-z","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/17 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Prostate, bladder and kidney neoplasms are among the most prevalent genitourinary (GU) cancers worldwide. Significant therapeutic advancements in recent years have substantially improved patient outcomes. In response to this rapid progress, the Santiago de Compostela Health Research Institute (IDIS) has organized the annual 'Cambados Consensus Forum on Genitourinary Tumors' (Pontevedra, Spain) since 2018. This 2-day multidisciplinary meeting gathers Spanish medical oncologists, radiation oncologists, urologists, and hospital pharmacists to present and discuss the latest evidence in the field, merging from international congresses or journal publications. This review provides an overview of the most recent evidence regarding therapeutic advances in prostate cancer, renal cell carcinoma, and bladder cancer presented at the 2024 meeting (October), with a special focus on practice-changing innovations.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

泌尿生殖系统癌的临床进展和实践更新：2024年多学科西班牙“坎巴多斯年会上”回顾。

前列腺、膀胱和肾脏肿瘤是世界上最常见的泌尿生殖系统（GU）癌症。近年来显著的治疗进展大大改善了患者的预后。为了应对这一快速进展，圣地亚哥德孔波斯特拉卫生研究所（IDIS）自2018年以来组织了一年一度的“坎巴多斯泌尿生殖系统肿瘤共识论坛”（西班牙蓬特维德拉）。这个为期两天的多学科会议聚集了西班牙医学肿瘤学家、放射肿瘤学家、泌尿科医生和医院药剂师，展示和讨论该领域的最新证据，这些证据来自国际会议或期刊出版物。这篇综述概述了2024年会议（10月）上关于前列腺癌、肾细胞癌和膀胱癌治疗进展的最新证据，特别关注改变实践的创新。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Clinical & Translational Oncology 医学-肿瘤学

CiteScore

6.20

自引率

2.90%

发文量

240

审稿时长

1 months

期刊介绍： Clinical and Translational Oncology is an international journal devoted to fostering interaction between experimental and clinical oncology. It covers all aspects of research on cancer, from the more basic discoveries dealing with both cell and molecular biology of tumour cells, to the most advanced clinical assays of conventional and new drugs. In addition, the journal has a strong commitment to facilitating the transfer of knowledge from the basic laboratory to the clinical practice, with the publication of educational series devoted to closing the gap between molecular and clinical oncologists. Molecular biology of tumours, identification of new targets for cancer therapy, and new technologies for research and treatment of cancer are the major themes covered by the educational series. Full research articles on a broad spectrum of subjects, including the molecular and cellular bases of disease, aetiology, pathophysiology, pathology, epidemiology, clinical features, and the diagnosis, prognosis and treatment of cancer, will be considered for publication.